home / stock / txg / txg news


TXG News and Press, 10x Genomics Inc. From 08/27/25

Stock Information

Company Name: 10x Genomics Inc.
Stock Symbol: TXG
Market: NASDAQ
Website: 10xgenomics.com

Menu

TXG TXG Quote TXG Short TXG News TXG Articles TXG Message Board
Get TXG Alerts

News, Short Squeeze, Breakout and More Instantly...

TXG - 10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that ...

TXG - Neutral Recommendation Issued On TXG By UBS

2025-08-08 10:15:19 ET UBS analyst issues NEUTRAL recommendation for TXG on August 8, 2025 11:45AM ET. The previous analyst recommendation was Neutral. TXG was trading at $12.06 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...

TXG - Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2025 Update

2025-08-07 21:09:12 ET This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 07/30/2025.... Read the full article on Seeking Alpha ...

TXG - 10x Genomics to acquire Scale Biosciences

2025-08-07 16:32:10 ET More on 10x Genomics 10x Genomics: Stuck In Neutral Life sciences tools companies higher as NIH pauses cancellation of research grants Bruker and 10x Genomics reach global settlement of patent litigation Seeking Alpha’s Quant Rat...

TXG - 10x Genomics GAAP EPS of $0.28 beats by $0.65, revenue of $172.9M beats by $33.39M

2025-08-07 16:20:31 ET More on 10x Genomics 10x Genomics: Stuck In Neutral Life sciences tools companies higher as NIH pauses cancellation of research grants Bruker and 10x Genomics reach global settlement of patent litigation Seeking Alpha’s Quant Rat...

TXG - 10x Genomics Reports Second Quarter 2025 Financial Results

10x Genomics Reports Second Quarter 2025 Financial Results PR Newswire PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter end...

TXG - 10x Genomics to Acquire Scale Biosciences

10x Genomics to Acquire Scale Biosciences PR Newswire Acquisition Will Further Expand Chromium's Capabilities PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today anno...

TXG - Expected US Company Earnings on Thursday, August 7th, 2025

Leatt Corp (LEAT) is expected to report for Q2 2025 MDU Resources Group Inc. (Holding Company) (MDU) is expected to report $0.13 for Q2 2025 Video Display Corp. (VIDE) is expected to report for quarter end 2025-05-31 Alarm.com Holdings Inc. (ALRM) is expected to report $0.38 for Q2 20...

TXG - Expected earnings - 10x Genomics Inc.

10x Genomics Inc. (TXG) is expected to report $-0.35 for Q2 2025

TXG - 10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery PR Newswire Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases ...

Previous 10 Next 10